|
Norpace CrDrug - Norpace Cr The trade name of the product as shown on the labeling.
Dosage -
CAPSULE, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Disopyramide Phosphate
Strength -
EQ 150MG BASE
Applicant -
GD SEARLE LLC
New Drug Application (NDA) Number -
018655
Product Number -
002
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Jul 20, 1982
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Gd Searle Llc
Norpace Cr
Persantine 50mg Tablet; Oral
Persantine 75mg Tablet; Oral Dynabac 250mg Tablet, Delayed Release; Oral Disopyramide Phosphate Eq 150mg Base Capsule, Extended Release; Oral Norpace Cr Eq 100mg Base Capsule, Extended Release; Oral Norpace Cr Eq 150mg Base Capsule, Extended Release; Oral Dipyridamole 50mg Tablet; Oral Dipyridamole 75mg Tablet; Oral Dipyridamole 50mg Tablet; Oral Persantine 25mg Tablet; Oral NewDrugInformation |